Mauro Perseghini

Title: Mauro Perseghini: Innovator in Pharmaceutical Chemistry

Introduction

Mauro Perseghini is a notable inventor based in Biasca, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds aimed at treating various medical conditions. With a total of two patents to his name, Perseghini's work is recognized for its potential impact on healthcare.

Latest Patents

Mauro Perseghini's latest patents include the fumarate salt of (R)-3-(1-(2,3-dichloro-4-(pyrazin-2-yl)phenyl)-2,2,2-trifluoroethyl)-1-methyl-1-(1-methylpiperidin-4-yl)urea. This invention encompasses methods of preparation and uses thereof, providing various embodiments related to the treatment of conditions associated with increased ghrelin levels, such as food abuse, alcohol addiction, and disorders like Prader-Willi syndrome. Additionally, his patents detail the crystalline HM04 free base and different crystalline forms of HM04 fumarate salt, along with methods for producing these compounds.

Career Highlights

Mauro Perseghini is currently associated with Helsinn Healthcare SA, a company known for its focus on innovative cancer treatments and supportive care. His work at Helsinn Healthcare has allowed him to contribute to the advancement of pharmaceutical solutions that address critical health issues.

Collaborations

Throughout his career, Mauro has collaborated with notable colleagues, including Silvina Garcia Rubio and Angelo Guainazzi. These partnerships have fostered a collaborative environment that enhances the innovation process within the pharmaceutical industry.

Conclusion

Mauro Perseghini stands out as an influential inventor in the realm of pharmaceutical chemistry. His patents reflect a commitment to addressing significant health challenges through innovative solutions. His contributions continue to shape the future of medical treatments and improve patient outcomes.